PXD063137
PXD063137 is an original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Naringenin targets PI3K p85alpha to suppress PI3K/AKT signaling pathway and ameliorate disordered MMP-9 secretion in cigarette smoke extract-induced alveolar macrophages in vitro |
| Description | Naringenin has demonstrated potential therapeutic effects against cigarette smoke-induced lung injury; however, its underlying mechanisms of regulating matrix metalloproteinase-9 (MMP-9) in alveolar macrophages remain unclear. Methods: The regulatory mechanisms of naringenin in cigarette smoke extract (CSE)-induced alveolar macrophages were investigated using proteomics, and then naringenin’s targets were further validated by western blot, molecular docking, molecular dynamics (MD) simu-lations, cellular thermal shift assay (CETSA), and enzyme activity assay. Results: The proteomics revealed that the PI3K/AKT signaling pathway might play a crucial role in naringenin’s inhibition of MMP-9. Western blot confirmed that naringenin significantly inhibited CSE-upregulated PI3K/AKT signaling pathway and reduced MMP-9 expression in MH-S cells. Notably, the PI3K activator 740Y-P reversed naringenin’s effects on MMP-9. Additionally, molecular docking, MD simulations, and CETSA identified PI3K p85alpha as the potential binding site for naringenin, and naringenin markedly inhibited CSE-induced PI3K activity. In in vitro experiments, naringenin inhibiting MMP-9 secre-tion in alveolar macrophages contributed to alleviating elastin and E-cadherin damage in alveolar epithelial cells. Furthermore, naringenin effectively suppressed CSE-induced MMP-9 secretion in primary mouse alveolar macrophages and human THP-1-differentiated macrophages. Conclusions: Our findings revealed that naringenin, a potential candidate for treating smoking-induced lung injury, directly targeted PI3K p85alpha, inhibiting PI3K activity and MMP-9 expression in CSE-induced alveolar macrophages via suppressing the PI3K/AKT signaling pathway. |
| HostingRepository | iProX |
| AnnounceDate | 2025-04-21 |
| AnnouncementXML | Submission_2025-07-02_00:00:59.270.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Weiyang Fan |
| SpeciesList | scientific name: Mus musculus; NCBI TaxID: 10090; |
| ModificationList | No PTMs are included in the dataset |
| Instrument | Q Exactive HF |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
|---|---|---|---|
| 0 | 2025-04-20 22:18:48 | ID requested | |
| 1 | 2025-04-24 02:18:37 | announced | |
| ⏵ 2 | 2025-07-02 00:01:00 | announced | 2025-07-02: Add info |
Publication List
| Fan W, Xu Z, Zhong M, Wu X, Chen P, Chen Z, Su W, Wu H, Li P, Naringenin Targets PI3K p85alpha to Suppress PI3K/AKT Signaling Pathway and Ameliorate Disordered MMP-9 Secretion in Cigarette Smoke Extract-Induced Alveolar Macrophages In Vitro. Cells, 14(10):(2025) [pubmed] |
Keyword List
| submitter keyword: MH-S cells, LC-MSMS, alveolar macrophage, cigarette, naringenin |
Contact List
| Peibo Li | |
|---|---|
| contact affiliation | School of Life Sciences, Sun Yat-sen University |
| contact email | lipeibo@mail.sysu.edu.cn |
| lab head | |
| Weiyang Fan | |
| contact affiliation | School of Life Sciences, Sun Yat-sen University |
| contact email | 2710053510@qq.com |
| dataset submitter | |
Full Dataset Link List
| iProX dataset URI |




